1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
A human monoclonal antibody bivalently binding two different epitopes in streptococcal M protein mediates immune function
(
- Contribution to journal › Article
- 2021
-
Mark
Suggested treatment of serious complications to COVID-19 vaccination with IdeS, a bacterial antibody-cleaving enzyme
(
- Contribution to journal › Letter
-
Mark
Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine : COMMENT from Gruel et al.: RESPONSE from Kahn et al.
(
- Contribution to journal › Letter
- 2018
-
Mark
Streptococcal inhibitor of complement (SIC) modulates fibrinolysis and enhances bacterial survival within fibrin clots
(
- Contribution to journal › Article
- 2015
-
Mark
Active but inoperable thrombin is accumulated in a plasma protein layer surrounding Streptococcus pyogenes.
(
- Contribution to journal › Article
- 2011
-
Mark
Antibacterial activity of the contact and complement systems is blocked by SIC, a protein secreted by Streptococcus pyogenes.
(
- Contribution to journal › Article
- 2010
-
Mark
Histidine-rich glycoprotein promotes bacterial entrapment in clots and decreases mortality in a mouse model of sepsis.
(
- Contribution to journal › Article
- 2009
-
Mark
Treatment of invasive streptococcal infection with a peptide derived from human high molecular weight kininogen.
(
- Contribution to journal › Article
- 2008
-
Mark
IgG glycan hydrolysis by a bacterial enzyme as a therapy against autoimmune conditions.
(
- Contribution to journal › Article
-
Mark
Antibodies against a surface protein of Streptococcus pyogenes promote a pathological inflammatory response.
(
- Contribution to journal › Article